Status:

COMPLETED

Effect of the LumbaCure® Intervention on Elderly Patients Suffering From cLBP.

Lead Sponsor:

Odix

Conditions:

Low Back Pain

Eligibility:

All Genders

60+ years

Phase:

NA

Brief Summary

The goal of this investigation is to evaluate the safety and efficacy of the LumbaCure® device in elderly people suffering from low back pain. The study is being carried out at several sites, in nursi...

Eligibility Criteria

Inclusion

  • Chronic or sub-acute low back pain (without "red flag")
  • The subject, a resident or worker at the investigation site (nursing home), over 60 years of age
  • Ability to communicate with the physiotherapist.
  • Ability to remain in a sitting position for at least 10 minutes.
  • A level of back pain \> 2 on the numerical pain rating scale

Exclusion

  • Suspected or confirmed serious pathology (infection, fracture, cancer, inflammatory arthritis, ....) related to the back/spine.
  • Body weight \> 120 kg
  • Subject is non-ambulatory or has severely reduced mobility.
  • Dominant component of radicular pain (common lumbago with distal radiation below the knee)
  • Radiculopathy
  • Severe cardiorespiratory disease
  • Dementia or significant cognitive impairment that prevents the participant from giving consent, completing study questionnaires or complying with recommendations.
  • Fracture or operation less than 3 months old of the spine, pelvis, hip or leg bones.
  • Known vertebral pathology other than osteoarthritis.
  • Major neurological disease, movement or motor neuron disorders
  • Fibromyalgia or other systemic rheumatic disease
  • Recent history of stroke or heart failure, unstable heart condition
  • Uncontrolled substance abuse disorders
  • Invasive procedures to relieve pain in the last 3 months
  • Acute or terminal illness
  • Any other medical condition considered by the study team to be a contraindication to the study.

Key Trial Info

Start Date :

December 11 2023

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 18 2024

Estimated Enrollment :

10 Patients enrolled

Trial Details

Trial ID

NCT06203886

Start Date

December 11 2023

End Date

July 18 2024

Last Update

August 29 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

ASBL " Mère Joséphine " - MRS Saint Joseph Blegny

Blégny, Liège, Belgium, 4670